story of the week
Intravenous Bevacizumab for Bleeding in Hereditary Hemorrhagic Telangiectasia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An International, Multicenter Study of Intravenous Bevacizumab for Bleeding in Hereditary Hemorrhagic Telangiectasia: The InHIBIT-Bleed Study
Haematologica 2020 Jul 16;[EPub Ahead of Print], H Al-Samkari, RS Kasthuri, JG Parambil, HA Albitar, YA Almodallal, C Vázquez, MM Serra, S Dupuis-Girod, CB Wilsen, JP McWilliams, EH Fountain, JR Gossage, CR Weiss, MA Latif, A Issachar, M Mei-Zahav, ME Meek, M Conrad, J Rodriguez-Lopez, DJ Kuter, VN IyerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.